Concentra Biosciences LLC, controlled by San Diego's Tang Capital Partners LP, made an unsolicited offer at $3 per share plus ...

Here's how an activist investor is threatening a Peninsula drug maker's merger plans. And the drama introduces a potential ...

As part of an agreement announced two weeks ago, eye-disease-focused Acelyrin was due to be absorbed into immune-mediated ...

Acelyrin earlier this month agreed to an all-stock merger with fellow immune player Alumis, with their combined cash tiding ...

Acelyrin (SLRN) “confirmed receipt of an unsolicited indication of interest from Concentra Biosciences, LLC, of which Tang Capital Partners, LP ...

In a report released on February 14, Tanushree Jain from Petra Capital maintained a Buy rating on Argenica Therapeutics Ltd (AGN – Research Report), with a price target of A$1.20. The company ...

Data is not available at this time. Insider Trading information for NDAQ is derived from Forms 3 and 4 filings filed with the U.S. Securities and Exchange Commission (SEC). Please Note:An FPI is ...

Roche Holding AG Akt-0.44% CHF238.46B ...

After hours: February 19 at 6:43:38 PM EST Loading Chart for KYTX ...

Sanofi S.A. Part Cert 0.02% €8.03M ...

After hours: February 18 at 6:00:12 PM EST Loading Chart for ADCT ...